Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.

PLoS One · 2019 · PMC6855454 · PMID 31725727

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)

However, the same samples tested for genotype II-specific neutralizing antibodies showed that LaSota group was significantly increased at 28 dpv (p = 0.031) and borderline significant at 14 dpv (p = 0.053) ( Fig 4D ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.